Jean-Michel Escoffre Jean-Michel Escoffre, PhD

Course and current status

Short CV                                                                                                              

2016: Permanent Researcher - Inserm (CRCN).

2015: Habilitation à Diriger la Recherche. University F. Rabelais, Tours, France.

2010: Ph.D. in Cell Biophysics. University P. Sabatier, Toulouse France.

Expertise in diagnostic tools, therapies and public health: ERC, H2020, ISF, FWO, ANR, ANRT,  Enhanced EuroTalents/CEA, Matwin, Ville de Paris, Région ïle de France.

Scientific awards: Young researcher award (2013), Planiol Foundation, France; Paul Sabatier award of biology (2011), Academy of Sciences, Toulouse, France; European Best Research Project Award in Nanotechnology (2013), EuroNanoForum.

Scientific summary

Since 2003, the main research interest of Jean-Michel Escoffre lies in the fields of drug and gene delivery methods (from the mechanisms to the clinical applications). He obtained with high honors his PhD Degree in Cell Biophysics in 2010 from the Institute of Pharmacology and Structural Biology (CNRS, UMR 5089) of the University P. Sabatier. During his PhD, his main research project was the study of molecular and cellular of plasmid DNA electrotransfer. From 2010 to 2013, he did postdoctoral research at the Institute of Imaging and Brain of the French Institute for Health and Medical Research (Inserm, UMR 930) in Tours, France. His main research interests lay in the fields of gene and drug delivery by microbubble-assisted ultrasound. From 2013 to 2015, he did postdoctoral research at Imaging Division of UMC Utrecht, The Netherlands. His main research project was the design of new protocols for therapeutic macromolecules delivery using high-intensity focused ultrasound guided by MRI. In 2016, he got his permanent position as Inserm researcher (CRCN Inserm). He is currently pursuing postdoctoral research at Inserm, UMR 1253, Tours, France and he is working on imaging-guided acoustically-mediated drug delivery. He is elected member of Research Council and Academic Council of University of Tours, and of Inserm CSS7 Technologies for Health.

Image d’exemple